Log in

OTCMKTS:EQURE-QURE Stock Price, Forecast & News

$0.08
0.00 (0.00 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.08
Now: $0.08
$0.08
50-Day Range
$0.06
MA: $0.09
$0.11
52-Week Range
$0.03
Now: $0.08
$0.16
Volume20 shs
Average Volume40 shs
Market Capitalization$2.59 million
P/E RatioN/A
Dividend YieldN/A
Beta3.22
E-Qure Corp. focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. E-Qure Corp. is based in New York, New York.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.72 out of 5 stars


Industry, Sector and Symbol

Industry Miscellaneous durable goods
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:EQUR
CUSIPN/A
CIKN/A
Phone972-5442-7777

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value($0.01) per share

Profitability

Miscellaneous

Employees1
Market Cap$2.59 million
Next Earnings Date9/24/2020 (Estimated)
OptionableNot Optionable

Receive EQUR News and Ratings via Email

Sign-up to receive the latest news and ratings for EQUR and its competitors with MarketBeat's FREE daily newsletter.

E-QURE (OTCMKTS:EQUR) Frequently Asked Questions

How has E-QURE's stock been impacted by COVID-19 (Coronavirus)?

E-QURE's stock was trading at $0.08 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, EQUR stock has decreased by 6.3% and is now trading at $0.0750. View which stocks have been most impacted by Coronavirus.

When is E-QURE's next earnings date?

E-QURE is scheduled to release its next quarterly earnings announcement on Thursday, September 24th 2020. View our earnings forecast for E-QURE.

Has E-QURE been receiving favorable news coverage?

Headlines about EQUR stock have been trending very negative on Monday, InfoTrie reports. The research group scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. E-QURE earned a daily sentiment score of -3.2 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news about E-QURE.

Who are some of E-QURE's key competitors?

What other stocks do shareholders of E-QURE own?

Who are E-QURE's key executives?

E-QURE's management team includes the following people:
  • Mr. Ohad Goren, CEO & Director (Age 48)
  • Mr. Gal Peleg, Chief Financial Officer (Age 41)
  • Mr. Itsik Ben Yesha, CTO & Director (Age 66)
  • Mr. Itai Weisberg, Chief Marketing Consultant

What is E-QURE's stock symbol?

E-QURE trades on the OTCMKTS under the ticker symbol "EQUR."

How do I buy shares of E-QURE?

Shares of EQUR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is E-QURE's stock price today?

One share of EQUR stock can currently be purchased for approximately $0.08.

How big of a company is E-QURE?

E-QURE has a market capitalization of $2.59 million. E-QURE employs 1 workers across the globe.

What is E-QURE's official website?

The official website for E-QURE is www.e-qure.com.

How can I contact E-QURE?

E-QURE's mailing address is 20 WEST 64TH STREET SUITE 39G, NEW YORK NY, 10023. The company can be reached via phone at 972-5442-7777.

This page was last updated on 7/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.